Mr. Glenn, the President of Access Healthcare Ltd which is the cooperator of MEBO in New Zealand and Australia, and Mr. Thompson, the Pharmaceutical Registration Consultant who is responsible for the registration of MEBO Products in New Zealand and Australia, together visited the Headquarter of MEBO International Group in China from Dec. 7th to Dec. 16th, 2005.
This is the seventh visit of Mr. Glenn to MEBO. During this visit, the two sides together reviewed the cooperative history and discussed the current situation.
The cooperative relationship between MEBO International Group and Access Healthcare Ltd was originally set up in 1998. Under the great efforts of two sides, there have been five kinds of MEBO Products distributed in New Zealand as natural plants skin care products, namely, MEBO Burn Repair, MEBO Ulcer Repair, MEBO Restore, MEBO Anti Itch Cream and MEBO Acne Clear.
Since MEBO Products went into the market in New Zealand, there have been thousands of local drug stores that sold them as the best products to treat skin problems. MEBO Products enjoy good reputation and public praise because of their excellent effectiveness. Statistically, every New Zealander has used at least one kind of MEBO products according to the population of New Zealand. Moreover, the sales volume in New Zealand consistently presents the tendency of right ascension.
At the same time when distributing products, Access Healthcare Ltd also focuses on the popularization of Tissue Organ Regenerative Medicine originally developed by MEBO. Thus, Access Healthcare Ltd especially trained every salesman and positively introduced Tissue Organ Regenerative Medicine of MEBO to hospitals, medical academic institutes, dermo-experts. All of these work have made a fairly proportion of New Zealanders acknowledge and accept this new and advanced medical science. It lays a solid groundwork for the development of New Zealand market.
Meanwhile, Ms. Zhang, Qian, the Executive President of MEBO International Group and the General Director of International Marketing Department, held several meetings with Mr. Glenn. The two sides all deeply understood the good situation and powerful development tendency in New Zealand and Australia market. The two sides decided to deepen bi-lateral cooperation in order to win greater success. Therefore, the two sides negotiated the new Cooperative Agreement and market strategy. This is one of the main purposes of Mr. Glenn's visit.
Year 2005 is ending, year 2006 is the important year for MEBO's development in New Zealand and Australia market. According to the market strategy together drawn up, the registration of MEBO Products has entered the counting down process. Mr. Thompson is invited by Access Healthcare Ltd as the Pharmaceutical Registration Consultant to take charge of the registration of MEBO Products in New Zealand and Australia. He has worked for Medsafe, the Pharmaceutical Registration Administration Department, and under his help, the registration of MEBO Products in New Zealand and Australia is going forward well. This investigation and visit of Mr. Thompson is just for the definitive preparation for the registration of MEBO Products as plant drugs in New Zealand and Australia. Now, both the two sides have thrown into the last stage to shoot for successful registration of MEBO Products as plant drugs in New Zealand and Australia, so that to provide a solid basis for the New Zealand and Australia market and even the entire international market.
Looking forward, with the consistent development of MEBO, MEBO is bound to wield more and more influences in New Zealand and Australia. Based on its high technology, unique mechanism and excellent effectiveness, MEBO will certainly enjoy more brilliant future!